# Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

> **NCT01741597** · PHASE1 · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Acinar Cell Adenocarcinoma of the Pancreas
- Duct Cell Adenocarcinoma of the Pancreas
- Liver Metastases
- Lung Metastases
- Recurrent Breast Cancer
- Recurrent Pancreatic Cancer
- Stage IV Breast Cancer
- Stage IV Pancreatic Cancer

## Interventions

- **PROCEDURE:** dynamic contrast-enhanced magnetic resonance imaging
- **OTHER:** pharmacological study
- **BIOLOGICAL:** tumor-homing peptide iRGD

## Key facts

- **NCT ID:** NCT01741597
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07
- **Primary completion:** 2016-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI chose to close the study
- **Last updated:** 2014-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01741597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01741597, "Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01741597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*